{
    "id": "2edttbcenrkv5x5v5pkg6u7potl5hnmd",
    "title": "Global ALS/MND \"big data\" collaboration environment in a post-PRO-ACT era",
    "info": {
        "author": [
            "Alexander Sherman, Massachusetts General Hospital"
        ],
        "published": "July 21, 2017",
        "recorded": "May 2017",
        "category": [
            "Top->Medicine",
            "Top->Medicine->Neuroscience"
        ]
    },
    "url": "http://videolectures.net/encals2017_sherman_global_ALS/",
    "segmentation": [
        [
            "I would like to thank the organizers and the scientific community for finally acknowledging my that my accent qualifies as European one.",
            "Thank you Leonard, especially so R. I will not be talking about a single trial study research project, but rather about a framework for collaborations for international corporations."
        ],
        [
            "I will be using some examples, but while I'm talking, I would love each and everyone of you here to think what could you use out of this presentation out of these tools and approaches.",
            "But also, what could you contribute data wise information wise to this research community.",
            "So as we know the dream of all researchers, here is how to turn each and every patient into research participant, usually 3 to 5% of patients participate in clinical research.",
            "In a less it's this number is close to 15%, but how to turn this everyone to be a participant in clinical research projects?",
            "So we collect all kinds of data or information on our pulse patients with their lesser people.",
            "People with a LS communities.",
            "So information from clinical trials, medical records, natural histories, bar banks, image banks, patient reported outcomes, genetics, omics or well lately, mobile apps.",
            "So we developed and there will be mentioning them.",
            "A couple of tools, the neurological Clinical Research Institute that are used quite widely but not sufficiently.",
            "I would say so.",
            "First of all, briefly mention data from clinical trials.",
            "We have a lot of or some at least industry people here, and I bet that most of them, if not all, used a database.",
            "A data set that is called Proact."
        ],
        [
            "So our product is pulled, resources, Open Access, LS, clinical trials data set where we approach pharmaceutical companies, but ask them to donate data from their clinical trials in companies like Terra Sanofi, Regeneron, Novartis.",
            "Biogen gave us their data.",
            "We added data from our Neil Sellers Consortium and we had 23 clinical trials data sets which we merged together.",
            "Harmonized client or anonymized and then.",
            "So this data set is the largest available 10,700 plus patients or subjects rather, and anyone literally anyone who is interested in analyzing this data set can go and download this, but prior to due to doing this kind of download permission.",
            "Or allowance rather, we decided to run a crowdsourcing challenge.",
            "Again, I will be mentioned this briefly because most of them are familiar with this was saying we said that here is 3 months worth of patients data.",
            "Could you predict what happens to patients in the year?",
            "And 11 and here's 50,000 dollars.",
            "1100 solvers from 64 countries downloaded data and we announced three winners instead of 1, and none of the winners had anything to do with LS nor with medicine.",
            "And one company from Washington to see that we're analyzing orders of perishable foods.",
            "So where one the price and they were so impressed that they spun off a bye informatics company originate and Dave and is here representative of this company.",
            "So that's what this company now does for living builds predictive models of war on urological diseases so."
        ],
        [
            "And anyone you including can go and download data.",
            "So one of the unique things here in this data set is the labs safety lapse.",
            "Usually no one cares about safety labs, as long as they are normal within normal ranges.",
            "So and some of the findings were within this safety lapse on which side of normality this values where?"
        ],
        [
            "So we have about 112 thousand Comet records there.",
            "We have 75,000 adverse events, so anyone who is interested in those Azan comments, actually they are normalized to standard dictionaries.",
            "So another challenge is our, where are the data as we know most of the data are not in clinical trials, but rather in clinical visits.",
            "How do we get data from clinical visits?",
            "Medical records certain are not the ideal source of medical data because they're not meant to keep medical data, so they're mostly for liabilities and billing.",
            "And if you go and start digging medical records, you may find vital signs gone.",
            "MATS, visits, procedures, but not necessarily structure.",
            "Talus, FRS, 4 forms or vital capacities, and so on, so, but most."
        ],
        [
            "Clinicians here, I bet keep their records from their patients somewhere in Excel spreadsheets and access databases on paper.",
            "Hoping that one day one day will come and they will have time to analyze.",
            "So this never happens, mostly.",
            "So what we were very much excited.",
            "Also, proactive, proactive data set to project and we decided to organize it Pro as data set where T stands for trials and E starts for research.",
            "And asking our clinicians so or international actual communities to bring their patients data that we will do the same, anonymized, harmonize and allow anyone to analyze and download.",
            "So the protocol for this was approved last October by mass General Hospital in Boston.",
            "But the challenge is that before someone gives me the data set I have to sign the data, use agreement with that person and in the data use agreement I have to spell out.",
            "What do I do with this data, anonymized or not, and my legal team at mass General Hospital asked me to spell out who will be seeing anonymized data, literally saying who will be seen.",
            "And while I'm saying that's the purpose of this entire project, anyone who wants to see will see.",
            "So unfortunately I don't have this legal agreement or.",
            "Approved by my hospital now one of the ideas I'm looking for, actually, or rather, collaborators for, as I'm trying to start an international data neurological data authority where both foundations and industry people and clinicians academia will bring data together and someone authorized will be distributing this data.",
            "Will help immensely, because in this case our institutions individual institutions will not feel.",
            "Liable for the data distribution, so I think that if anyone has any ideas, funding or just willingness to join this project with me, please meet me after the meeting or during the meeting so."
        ],
        [
            "Are so this is the our model for price out of 1st 20 clinicians we discovered 15,000 records.",
            "So this project is on hold, but hopefully I isn't hold.",
            "But I hope that this year it will be restarted."
        ],
        [
            "So another challenge for us is there so when the patient comes in, person comes into clinical research project.",
            "The subject ID is being assigned to this person and then you collect data information based on this subject idea.",
            "When the same person comes again to you or somewhere else and you subject lady is being assigned and there is no way to connect the data.",
            "So we came up with this idea of Neuro Global unique identifier.",
            "So why not just global unique identifier?",
            "Because then it will be an international medical record that it's not politically correct to have such a thing.",
            "So, but if it's for a specific disease area, it's acceptable.",
            "So we developed the."
        ],
        [
            "A tool called neurological Global unique identifier.",
            "When you enter information or for a patient, so this information on this client side is being hashed encrypted.",
            "Sorry for the tech talk being sent to the server and the server returns a random string 11 character string.",
            "First 3 characters.",
            "Any you identify that it's in urological global unique identifier and then eight random characters.",
            "And every time you enter the same information, this same string is returned.",
            "So this shrink cannot reverse engineered back to the information because the server has no idea what was initially in that entered for the patient."
        ],
        [
            "We also developed a platform called your bank.",
            "Some of you maybe even using this platform as part of certain studies, and the platform allows you to create a patient with this neurological global unique identifier.",
            "And then you say so this patient consented to this particular study and visits and forms for this patient for this study.",
            "For this study team become available for data entry and data viewing.",
            "You have the same person, consents to a different study, only that second team will be seeing.",
            "Data from for this study, so, and they may not even suspect that this to a patient with spades in several studies.",
            "But if this PR is agreed to collaborate so suddenly certain information that makes no sense to reenter, or even to collect like demographics, disease, history, family history, and so, and so on become immediately available for the 2nd, 5th intense team since one so or currently."
        ],
        [
            "We have 22.",
            "22 LS related studies in this new bank platform.",
            "So as you can see, most of them collect clinical data or some of them collect so 10 collect Dnas.",
            "Most about what's 14 collector bar fluids and so on and so forth.",
            "So three collect mobile apps and the idea is to create this research continuum if you wish, where patients but it's paid in multiple studies during their lifetime.",
            "And I'm not talking about clinical trials but rather clinical research projects, collecting DNA collecting by fluids, mobile app visits to the clinics, and so on."
        ],
        [
            "So are at currently, so this is what we have.",
            "We have 22 studies with 26880 enrolled patients LS patients, so we have a interesting enough so we have two 205 volunteers who participate in more than one study.",
            "At 2 volunteers participate in five steps simultaneously.",
            "So we have 880 DNA is collected.",
            "And actually this DNA samples are being sent to New York Genome Center and.",
            "Being sequenced at anyone can download.",
            "Ask for these samples right now using your logical global global unique identifier, so our and all this by fluids that you can see here about 35,000 by fluids of I'll survive fluids are also readily available and anyone interested in this fire flutes can go to website Neil's website and ask for this by fluids.",
            "So basically it's a huge enormous research that is.",
            "Will be bigger and bigger.",
            "It's growing, so the total amount of involvement, or rather the total enrollment goal currently is 6000, but it's growing as well.",
            "They would like to use this opportunity to thank our sponsors and Lucy here.",
            "Version as Lucy.",
            "I really appreciate your vision.",
            "And are encouraged to sponsor this project.",
            "So and."
        ],
        [
            "I just want to talk a minute to talk about.",
            "Take a minute to talk about Natural History studies so we are in the age of precision medicine here, and I believe that more and more we can see where rare diseases elessons, including will be seen as an ultra rare disease.",
            "If you go after SG-1 mutations or C9 or mutation and then maybe even more and more are smaller disease populations.",
            "So and it will be next to impossible to use standard classical, placebo controlled models for clinical trials.",
            "We don't have enough patience in this sub populations and especially with the new I don't know, so some are definitely there are people here who know more than I do, but it seems with the GNU FDA chief.",
            "So are I read couple of his papers.",
            "The idea is that a natural histories may be used or will be used as.",
            "Control arms for clinical trials for controlled clinical trials.",
            "So I think that there is a huge need and necessity for us to start this before it's being announced and start collecting natural histories.",
            "So in this one of 22 studies that I showed, we have a Natural History in LS study and the idea behind is that to collect everyone so product data set is a great resource, but it contains data from clinical trials, meaning that there are possible control issues there.",
            "It also clinical trials selection bars.",
            "So what do we do in this?",
            "We ran so this."
        ],
        [
            "Is the.",
            "Slide from our dublins abstract here so the in proactively LSF arrest slope was minus 106 while in our in Natural History minus .7 three.",
            "So because everyone is included colluding slow progressors and so on.",
            "So this is another interesting slide.",
            "So this is distribution of LSF.",
            "Rate FRS.",
            "Our monthly drop rate or monthly.",
            "Great, because as you can see just from one study from one side, there is a huge distribution from positive one to minus 3.5.",
            "So."
        ],
        [
            "So we developed by repository that used the same global unique identifier."
        ],
        [
            "Under diced asopis standardized."
        ],
        [
            "Nomenclature."
        ],
        [
            "So anyone can go to news website and search for availability.",
            "We have postmortem tissues as well collection by run by target."
        ],
        [
            "Class, But another interesting point."
        ],
        [
            "Point is patient whoops, sorry for this.",
            "So we have patient portal.",
            "So basically information that is quite missing and I do know I talked to some of my European colleagues and they don't trust patients opinions.",
            "So in the state it's more and more prevalent to to ask patients what do they want us to study and so on.",
            "So we created patient portal that allows them to self."
        ],
        [
            "Register join join this study or enter information, consent online and then."
        ],
        [
            "Based on this information we can."
        ],
        [
            "Literally say."
        ],
        [
            "These are these studies for which you're eligible, they can."
        ],
        [
            "Select a study."
        ],
        [
            "Of two"
        ],
        [
            "Each day, so for this patient there are two studies."
        ],
        [
            "Bailable so this consent for this particular."
        ],
        [
            "Study."
        ],
        [
            "And then we asking them to collect longitudinally."
        ],
        [
            "ETA for this?"
        ],
        [
            "This study"
        ],
        [
            "R."
        ],
        [
            "And this is huge, so."
        ],
        [
            "So we have one study in Microbio, so where patients consent online and then based on their consent and after the peize confirmed that this their diagnosis a kid is being sent to them to their homes and they send the kid back to the Broad Institute for Microbiome now."
        ],
        [
            "This is."
        ],
        [
            "So we can."
        ],
        [
            "Do something like patientslikeme.",
            "I know that their sponsors here so so, but the idea is to have this same kind of analytical tools at your desktop while you do around your clinical studies."
        ],
        [
            "From you."
        ],
        [
            "Bank."
        ],
        [
            "So another interesting thing is patients perspective.",
            "Who is asking patients to tell us what's important for them?",
            "So we would study pain or gate and so on.",
            "So this is an example from other diseases, but it shows clearly that patients have their own ideas.",
            "What would they like us to?"
        ],
        [
            "So basically in conclusion, I just wanted to say that that's the."
        ],
        [
            "The local, so how to paint put patient into the center and make each and every pool to be a study participant or rather collaborator."
        ],
        [
            "So two in conclusion, I would love to say that there's some things that I would love to leave you with.",
            "So first of all, I believe that good is newer, good isation of files communities in most, regardless whether you want to collaborate, whether you want to or even consider sharing your data eventually will we will be forced all to share data on our patients so the development of the incentives.",
            "It's quite an interesting thing, because how do we consider Co authorship?",
            "If my data were used in your paper?",
            "So one of the ideas were circulating that everyone will be an equal coauthor, but then whom to contribute to?",
            "Consider a collaborator versus contributor versus just so if one someone can contribute it, one patient.",
            "Is it enough?",
            "Is it or is it 50 patients or 5000 patients and so on.",
            "Legal matters are important, so all these three letter words like data use, agreement, MTS, ICF's and so on.",
            "So we develop our standard language and anyone can welcome to use it.",
            "And some of you use it for our International Studies and then our anyone.",
            "It's free to start using this new bank platform.",
            "So you're more than welcome."
        ],
        [
            "I would like to thank my team and my collaborators, investigators and sponsors.",
            "Thank you."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I would like to thank the organizers and the scientific community for finally acknowledging my that my accent qualifies as European one.",
                    "label": 0
                },
                {
                    "sent": "Thank you Leonard, especially so R. I will not be talking about a single trial study research project, but rather about a framework for collaborations for international corporations.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "I will be using some examples, but while I'm talking, I would love each and everyone of you here to think what could you use out of this presentation out of these tools and approaches.",
                    "label": 0
                },
                {
                    "sent": "But also, what could you contribute data wise information wise to this research community.",
                    "label": 0
                },
                {
                    "sent": "So as we know the dream of all researchers, here is how to turn each and every patient into research participant, usually 3 to 5% of patients participate in clinical research.",
                    "label": 0
                },
                {
                    "sent": "In a less it's this number is close to 15%, but how to turn this everyone to be a participant in clinical research projects?",
                    "label": 0
                },
                {
                    "sent": "So we collect all kinds of data or information on our pulse patients with their lesser people.",
                    "label": 0
                },
                {
                    "sent": "People with a LS communities.",
                    "label": 0
                },
                {
                    "sent": "So information from clinical trials, medical records, natural histories, bar banks, image banks, patient reported outcomes, genetics, omics or well lately, mobile apps.",
                    "label": 1
                },
                {
                    "sent": "So we developed and there will be mentioning them.",
                    "label": 1
                },
                {
                    "sent": "A couple of tools, the neurological Clinical Research Institute that are used quite widely but not sufficiently.",
                    "label": 0
                },
                {
                    "sent": "I would say so.",
                    "label": 0
                },
                {
                    "sent": "First of all, briefly mention data from clinical trials.",
                    "label": 0
                },
                {
                    "sent": "We have a lot of or some at least industry people here, and I bet that most of them, if not all, used a database.",
                    "label": 0
                },
                {
                    "sent": "A data set that is called Proact.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So our product is pulled, resources, Open Access, LS, clinical trials data set where we approach pharmaceutical companies, but ask them to donate data from their clinical trials in companies like Terra Sanofi, Regeneron, Novartis.",
                    "label": 0
                },
                {
                    "sent": "Biogen gave us their data.",
                    "label": 0
                },
                {
                    "sent": "We added data from our Neil Sellers Consortium and we had 23 clinical trials data sets which we merged together.",
                    "label": 0
                },
                {
                    "sent": "Harmonized client or anonymized and then.",
                    "label": 0
                },
                {
                    "sent": "So this data set is the largest available 10,700 plus patients or subjects rather, and anyone literally anyone who is interested in analyzing this data set can go and download this, but prior to due to doing this kind of download permission.",
                    "label": 0
                },
                {
                    "sent": "Or allowance rather, we decided to run a crowdsourcing challenge.",
                    "label": 0
                },
                {
                    "sent": "Again, I will be mentioned this briefly because most of them are familiar with this was saying we said that here is 3 months worth of patients data.",
                    "label": 0
                },
                {
                    "sent": "Could you predict what happens to patients in the year?",
                    "label": 0
                },
                {
                    "sent": "And 11 and here's 50,000 dollars.",
                    "label": 0
                },
                {
                    "sent": "1100 solvers from 64 countries downloaded data and we announced three winners instead of 1, and none of the winners had anything to do with LS nor with medicine.",
                    "label": 0
                },
                {
                    "sent": "And one company from Washington to see that we're analyzing orders of perishable foods.",
                    "label": 0
                },
                {
                    "sent": "So where one the price and they were so impressed that they spun off a bye informatics company originate and Dave and is here representative of this company.",
                    "label": 0
                },
                {
                    "sent": "So that's what this company now does for living builds predictive models of war on urological diseases so.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And anyone you including can go and download data.",
                    "label": 0
                },
                {
                    "sent": "So one of the unique things here in this data set is the labs safety lapse.",
                    "label": 0
                },
                {
                    "sent": "Usually no one cares about safety labs, as long as they are normal within normal ranges.",
                    "label": 0
                },
                {
                    "sent": "So and some of the findings were within this safety lapse on which side of normality this values where?",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So we have about 112 thousand Comet records there.",
                    "label": 0
                },
                {
                    "sent": "We have 75,000 adverse events, so anyone who is interested in those Azan comments, actually they are normalized to standard dictionaries.",
                    "label": 0
                },
                {
                    "sent": "So another challenge is our, where are the data as we know most of the data are not in clinical trials, but rather in clinical visits.",
                    "label": 0
                },
                {
                    "sent": "How do we get data from clinical visits?",
                    "label": 0
                },
                {
                    "sent": "Medical records certain are not the ideal source of medical data because they're not meant to keep medical data, so they're mostly for liabilities and billing.",
                    "label": 0
                },
                {
                    "sent": "And if you go and start digging medical records, you may find vital signs gone.",
                    "label": 0
                },
                {
                    "sent": "MATS, visits, procedures, but not necessarily structure.",
                    "label": 0
                },
                {
                    "sent": "Talus, FRS, 4 forms or vital capacities, and so on, so, but most.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Clinicians here, I bet keep their records from their patients somewhere in Excel spreadsheets and access databases on paper.",
                    "label": 0
                },
                {
                    "sent": "Hoping that one day one day will come and they will have time to analyze.",
                    "label": 0
                },
                {
                    "sent": "So this never happens, mostly.",
                    "label": 0
                },
                {
                    "sent": "So what we were very much excited.",
                    "label": 0
                },
                {
                    "sent": "Also, proactive, proactive data set to project and we decided to organize it Pro as data set where T stands for trials and E starts for research.",
                    "label": 0
                },
                {
                    "sent": "And asking our clinicians so or international actual communities to bring their patients data that we will do the same, anonymized, harmonize and allow anyone to analyze and download.",
                    "label": 0
                },
                {
                    "sent": "So the protocol for this was approved last October by mass General Hospital in Boston.",
                    "label": 0
                },
                {
                    "sent": "But the challenge is that before someone gives me the data set I have to sign the data, use agreement with that person and in the data use agreement I have to spell out.",
                    "label": 0
                },
                {
                    "sent": "What do I do with this data, anonymized or not, and my legal team at mass General Hospital asked me to spell out who will be seeing anonymized data, literally saying who will be seen.",
                    "label": 0
                },
                {
                    "sent": "And while I'm saying that's the purpose of this entire project, anyone who wants to see will see.",
                    "label": 0
                },
                {
                    "sent": "So unfortunately I don't have this legal agreement or.",
                    "label": 0
                },
                {
                    "sent": "Approved by my hospital now one of the ideas I'm looking for, actually, or rather, collaborators for, as I'm trying to start an international data neurological data authority where both foundations and industry people and clinicians academia will bring data together and someone authorized will be distributing this data.",
                    "label": 0
                },
                {
                    "sent": "Will help immensely, because in this case our institutions individual institutions will not feel.",
                    "label": 0
                },
                {
                    "sent": "Liable for the data distribution, so I think that if anyone has any ideas, funding or just willingness to join this project with me, please meet me after the meeting or during the meeting so.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Are so this is the our model for price out of 1st 20 clinicians we discovered 15,000 records.",
                    "label": 0
                },
                {
                    "sent": "So this project is on hold, but hopefully I isn't hold.",
                    "label": 0
                },
                {
                    "sent": "But I hope that this year it will be restarted.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So another challenge for us is there so when the patient comes in, person comes into clinical research project.",
                    "label": 0
                },
                {
                    "sent": "The subject ID is being assigned to this person and then you collect data information based on this subject idea.",
                    "label": 0
                },
                {
                    "sent": "When the same person comes again to you or somewhere else and you subject lady is being assigned and there is no way to connect the data.",
                    "label": 0
                },
                {
                    "sent": "So we came up with this idea of Neuro Global unique identifier.",
                    "label": 0
                },
                {
                    "sent": "So why not just global unique identifier?",
                    "label": 0
                },
                {
                    "sent": "Because then it will be an international medical record that it's not politically correct to have such a thing.",
                    "label": 0
                },
                {
                    "sent": "So, but if it's for a specific disease area, it's acceptable.",
                    "label": 0
                },
                {
                    "sent": "So we developed the.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "A tool called neurological Global unique identifier.",
                    "label": 0
                },
                {
                    "sent": "When you enter information or for a patient, so this information on this client side is being hashed encrypted.",
                    "label": 0
                },
                {
                    "sent": "Sorry for the tech talk being sent to the server and the server returns a random string 11 character string.",
                    "label": 0
                },
                {
                    "sent": "First 3 characters.",
                    "label": 0
                },
                {
                    "sent": "Any you identify that it's in urological global unique identifier and then eight random characters.",
                    "label": 0
                },
                {
                    "sent": "And every time you enter the same information, this same string is returned.",
                    "label": 0
                },
                {
                    "sent": "So this shrink cannot reverse engineered back to the information because the server has no idea what was initially in that entered for the patient.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We also developed a platform called your bank.",
                    "label": 0
                },
                {
                    "sent": "Some of you maybe even using this platform as part of certain studies, and the platform allows you to create a patient with this neurological global unique identifier.",
                    "label": 0
                },
                {
                    "sent": "And then you say so this patient consented to this particular study and visits and forms for this patient for this study.",
                    "label": 0
                },
                {
                    "sent": "For this study team become available for data entry and data viewing.",
                    "label": 0
                },
                {
                    "sent": "You have the same person, consents to a different study, only that second team will be seeing.",
                    "label": 0
                },
                {
                    "sent": "Data from for this study, so, and they may not even suspect that this to a patient with spades in several studies.",
                    "label": 0
                },
                {
                    "sent": "But if this PR is agreed to collaborate so suddenly certain information that makes no sense to reenter, or even to collect like demographics, disease, history, family history, and so, and so on become immediately available for the 2nd, 5th intense team since one so or currently.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We have 22.",
                    "label": 0
                },
                {
                    "sent": "22 LS related studies in this new bank platform.",
                    "label": 0
                },
                {
                    "sent": "So as you can see, most of them collect clinical data or some of them collect so 10 collect Dnas.",
                    "label": 0
                },
                {
                    "sent": "Most about what's 14 collector bar fluids and so on and so forth.",
                    "label": 0
                },
                {
                    "sent": "So three collect mobile apps and the idea is to create this research continuum if you wish, where patients but it's paid in multiple studies during their lifetime.",
                    "label": 0
                },
                {
                    "sent": "And I'm not talking about clinical trials but rather clinical research projects, collecting DNA collecting by fluids, mobile app visits to the clinics, and so on.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So are at currently, so this is what we have.",
                    "label": 0
                },
                {
                    "sent": "We have 22 studies with 26880 enrolled patients LS patients, so we have a interesting enough so we have two 205 volunteers who participate in more than one study.",
                    "label": 1
                },
                {
                    "sent": "At 2 volunteers participate in five steps simultaneously.",
                    "label": 0
                },
                {
                    "sent": "So we have 880 DNA is collected.",
                    "label": 0
                },
                {
                    "sent": "And actually this DNA samples are being sent to New York Genome Center and.",
                    "label": 0
                },
                {
                    "sent": "Being sequenced at anyone can download.",
                    "label": 0
                },
                {
                    "sent": "Ask for these samples right now using your logical global global unique identifier, so our and all this by fluids that you can see here about 35,000 by fluids of I'll survive fluids are also readily available and anyone interested in this fire flutes can go to website Neil's website and ask for this by fluids.",
                    "label": 0
                },
                {
                    "sent": "So basically it's a huge enormous research that is.",
                    "label": 1
                },
                {
                    "sent": "Will be bigger and bigger.",
                    "label": 0
                },
                {
                    "sent": "It's growing, so the total amount of involvement, or rather the total enrollment goal currently is 6000, but it's growing as well.",
                    "label": 0
                },
                {
                    "sent": "They would like to use this opportunity to thank our sponsors and Lucy here.",
                    "label": 0
                },
                {
                    "sent": "Version as Lucy.",
                    "label": 0
                },
                {
                    "sent": "I really appreciate your vision.",
                    "label": 0
                },
                {
                    "sent": "And are encouraged to sponsor this project.",
                    "label": 0
                },
                {
                    "sent": "So and.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I just want to talk a minute to talk about.",
                    "label": 0
                },
                {
                    "sent": "Take a minute to talk about Natural History studies so we are in the age of precision medicine here, and I believe that more and more we can see where rare diseases elessons, including will be seen as an ultra rare disease.",
                    "label": 0
                },
                {
                    "sent": "If you go after SG-1 mutations or C9 or mutation and then maybe even more and more are smaller disease populations.",
                    "label": 0
                },
                {
                    "sent": "So and it will be next to impossible to use standard classical, placebo controlled models for clinical trials.",
                    "label": 0
                },
                {
                    "sent": "We don't have enough patience in this sub populations and especially with the new I don't know, so some are definitely there are people here who know more than I do, but it seems with the GNU FDA chief.",
                    "label": 0
                },
                {
                    "sent": "So are I read couple of his papers.",
                    "label": 0
                },
                {
                    "sent": "The idea is that a natural histories may be used or will be used as.",
                    "label": 0
                },
                {
                    "sent": "Control arms for clinical trials for controlled clinical trials.",
                    "label": 0
                },
                {
                    "sent": "So I think that there is a huge need and necessity for us to start this before it's being announced and start collecting natural histories.",
                    "label": 0
                },
                {
                    "sent": "So in this one of 22 studies that I showed, we have a Natural History in LS study and the idea behind is that to collect everyone so product data set is a great resource, but it contains data from clinical trials, meaning that there are possible control issues there.",
                    "label": 0
                },
                {
                    "sent": "It also clinical trials selection bars.",
                    "label": 0
                },
                {
                    "sent": "So what do we do in this?",
                    "label": 0
                },
                {
                    "sent": "We ran so this.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Is the.",
                    "label": 0
                },
                {
                    "sent": "Slide from our dublins abstract here so the in proactively LSF arrest slope was minus 106 while in our in Natural History minus .7 three.",
                    "label": 0
                },
                {
                    "sent": "So because everyone is included colluding slow progressors and so on.",
                    "label": 0
                },
                {
                    "sent": "So this is another interesting slide.",
                    "label": 0
                },
                {
                    "sent": "So this is distribution of LSF.",
                    "label": 0
                },
                {
                    "sent": "Rate FRS.",
                    "label": 0
                },
                {
                    "sent": "Our monthly drop rate or monthly.",
                    "label": 0
                },
                {
                    "sent": "Great, because as you can see just from one study from one side, there is a huge distribution from positive one to minus 3.5.",
                    "label": 0
                },
                {
                    "sent": "So.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So we developed by repository that used the same global unique identifier.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Under diced asopis standardized.",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Nomenclature.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So anyone can go to news website and search for availability.",
                    "label": 0
                },
                {
                    "sent": "We have postmortem tissues as well collection by run by target.",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Class, But another interesting point.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Point is patient whoops, sorry for this.",
                    "label": 0
                },
                {
                    "sent": "So we have patient portal.",
                    "label": 0
                },
                {
                    "sent": "So basically information that is quite missing and I do know I talked to some of my European colleagues and they don't trust patients opinions.",
                    "label": 0
                },
                {
                    "sent": "So in the state it's more and more prevalent to to ask patients what do they want us to study and so on.",
                    "label": 0
                },
                {
                    "sent": "So we created patient portal that allows them to self.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Register join join this study or enter information, consent online and then.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Based on this information we can.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Literally say.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "These are these studies for which you're eligible, they can.",
                    "label": 0
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Select a study.",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Of two",
                    "label": 0
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Each day, so for this patient there are two studies.",
                    "label": 0
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Bailable so this consent for this particular.",
                    "label": 0
                }
            ]
        },
        "clip_28": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Study.",
                    "label": 0
                }
            ]
        },
        "clip_29": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then we asking them to collect longitudinally.",
                    "label": 0
                }
            ]
        },
        "clip_30": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "ETA for this?",
                    "label": 0
                }
            ]
        },
        "clip_31": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This study",
                    "label": 0
                }
            ]
        },
        "clip_32": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "R.",
                    "label": 0
                }
            ]
        },
        "clip_33": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And this is huge, so.",
                    "label": 0
                }
            ]
        },
        "clip_34": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So we have one study in Microbio, so where patients consent online and then based on their consent and after the peize confirmed that this their diagnosis a kid is being sent to them to their homes and they send the kid back to the Broad Institute for Microbiome now.",
                    "label": 0
                }
            ]
        },
        "clip_35": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This is.",
                    "label": 0
                }
            ]
        },
        "clip_36": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So we can.",
                    "label": 0
                }
            ]
        },
        "clip_37": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Do something like patientslikeme.",
                    "label": 0
                },
                {
                    "sent": "I know that their sponsors here so so, but the idea is to have this same kind of analytical tools at your desktop while you do around your clinical studies.",
                    "label": 0
                }
            ]
        },
        "clip_38": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "From you.",
                    "label": 0
                }
            ]
        },
        "clip_39": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Bank.",
                    "label": 0
                }
            ]
        },
        "clip_40": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So another interesting thing is patients perspective.",
                    "label": 0
                },
                {
                    "sent": "Who is asking patients to tell us what's important for them?",
                    "label": 0
                },
                {
                    "sent": "So we would study pain or gate and so on.",
                    "label": 0
                },
                {
                    "sent": "So this is an example from other diseases, but it shows clearly that patients have their own ideas.",
                    "label": 0
                },
                {
                    "sent": "What would they like us to?",
                    "label": 0
                }
            ]
        },
        "clip_41": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So basically in conclusion, I just wanted to say that that's the.",
                    "label": 0
                }
            ]
        },
        "clip_42": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The local, so how to paint put patient into the center and make each and every pool to be a study participant or rather collaborator.",
                    "label": 0
                }
            ]
        },
        "clip_43": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So two in conclusion, I would love to say that there's some things that I would love to leave you with.",
                    "label": 0
                },
                {
                    "sent": "So first of all, I believe that good is newer, good isation of files communities in most, regardless whether you want to collaborate, whether you want to or even consider sharing your data eventually will we will be forced all to share data on our patients so the development of the incentives.",
                    "label": 0
                },
                {
                    "sent": "It's quite an interesting thing, because how do we consider Co authorship?",
                    "label": 0
                },
                {
                    "sent": "If my data were used in your paper?",
                    "label": 0
                },
                {
                    "sent": "So one of the ideas were circulating that everyone will be an equal coauthor, but then whom to contribute to?",
                    "label": 0
                },
                {
                    "sent": "Consider a collaborator versus contributor versus just so if one someone can contribute it, one patient.",
                    "label": 0
                },
                {
                    "sent": "Is it enough?",
                    "label": 0
                },
                {
                    "sent": "Is it or is it 50 patients or 5000 patients and so on.",
                    "label": 0
                },
                {
                    "sent": "Legal matters are important, so all these three letter words like data use, agreement, MTS, ICF's and so on.",
                    "label": 0
                },
                {
                    "sent": "So we develop our standard language and anyone can welcome to use it.",
                    "label": 0
                },
                {
                    "sent": "And some of you use it for our International Studies and then our anyone.",
                    "label": 0
                },
                {
                    "sent": "It's free to start using this new bank platform.",
                    "label": 0
                },
                {
                    "sent": "So you're more than welcome.",
                    "label": 0
                }
            ]
        },
        "clip_44": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I would like to thank my team and my collaborators, investigators and sponsors.",
                    "label": 0
                },
                {
                    "sent": "Thank you.",
                    "label": 0
                }
            ]
        }
    }
}